Sherwin-Williams shares rose 5.1% following better-than-expected sales and margin performance, supported by broad-based growth and an increased full-year guidance. Investors rewarded execution on new account wins, pricing discipline, and margin expansion despite ongoing demand challenges.
Sherwin-Williams shares fell 5.4% following Q1 results, as management’s unchanged full-year outlook and comments on persistent end-market softness and rising uncertainty appeared to disappoint investors looking for a more constructive guidance or clearer signs of accelerating demand.
Sherwin-Williams reported solid Q3 2025 results, with sales growth outpacing softer demand conditions, as strategic investments continue to yield returns amid a challenging economic backdrop.